CTOs on the Move

Garden of Life, Inc.

www.gardenoflife.com

 
Garden of Life, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in West Palm Beach, FL. To find more information about Garden of Life, Inc., please visit www.gardenoflife.com
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.gardenoflife.com
  • 5500 Village Blvd Ste 202
    West Palm Beach, FL USA 33407-1961
  • Phone: 561.748.2477

Executives

Name Title Contact Details

Similar Companies

Androscoggin Valley Hospital, Inc.

Androscoggin Valley Hospital, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Berlin, NH. To find more information about Androscoggin Valley Hospital, Inc., please visit www.avhnh.org

Bluegrass Family Health

Bluegrass Family Health, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Bluegrass Family Health, Inc. is based in Lexington, KY. You can find more information on Bluegrass Family Health, Inc. at www.bgfh.com

BewellConnect Corp

BewellConnect Corp. is an ecosystem of connected devices and services that enhance care coordination.

Daniel Jarvis Home Health Private

Daniel Jarvis Home Health Private is a Bryan, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ritter Pharmaceuticals

Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.